obtained
by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine ,
In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .
In contrast , highly mannosylated HBV , obtained by treating HBV producing HepG2.2.15 cells with the a - mannosidase I inhibitor kifunensine , is recognized by DC - SIGN .